Advertisement

Low and Loss of Vision in the Elderly

  • Nages Nagaratnam
  • Kujan Nagaratnam
  • Gary Cheuk
Chapter
  • 1.8k Downloads

Abstract

Age-related changes occur in all structures of the eye causing varied effects. With ageing, lens opacities and changes in the vitreous occur and the vitreous gel undergoes liquefaction. A number of changes occur in the retina including accumulation of lipofuscin, thickening of Bruch’s membrane, narrowing of the choroidal arteries and accumulation of material forming soft drusen. The four main causes of low or loss of vision are age-related macular degeneration (AMD), glaucoma, cataract and diabetic retinopathy. The pathophysiology of AMD is complex and unclear, and the pathological processes implicated are accumulation of lipofuscin, formation of drusen, neovascularisation and inflammation. Complement system plays a vital role in the pathology of AMD. In glaucoma, elevated intraocular pressure and vascular dysfunction are said to contribute to initial insult and the ultimate result is death of the retinal ganglion cells causing irreversible visual loss. Cataract of old age is multifactorial with genetic, environmental and biochemical factors which act synergistically. A number of biochemical pathways have been proposed as possible links between hyperglycaemia and diabetic retinopathy (DR). The instrumental pathways include increased polyol pathway, activation of protein kinase C and increase exposure of growth factors such as vascular endothelial growth factor (VEGF).

Keywords

Age-related changes Age-related macular degeneration Vascular endothelial growth factor (VEGF) Cataract Glaucoma Diabetic retinopathy 

References

  1. 1.
    Salvi SM, Akhtar S, Currie Z. Ageing changes in the eye. Postgrad Med J. 2006;82:581–7.PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Cassim R. The ageing eye. CME. 2007;25(10):484–9.Google Scholar
  3. 3.
    Niesel P. Visible changes of the lens with age. Trans Ophthalmol Soc UK. 1982;102:327–30 (abstract).PubMedGoogle Scholar
  4. 4.
    van den Berg TJTP, van Rijn LJ (Rene), Kasper-Bongers R, et al. Disability glare in the aging eye. Assessments and impact on driving. J Optom. 2009;02(03):112–8.Google Scholar
  5. 5.
    Ducan G, Weale RA. Physical changes due to aged cataracts. In: Ducan G, editor. Mechanisms of cataract formation in the human lens. London: Academic Press; 1981. p. 47–70.Google Scholar
  6. 6.
    Boniha VL. Age and disease-related structural changes in the retinal pigment epithelium. Clin Ophthalmol. 2008;2(2):413–24.CrossRefGoogle Scholar
  7. 7.
    Sarks J, Sarks S. Age related macular degeneration. Australian doctor. 28 Sept 2001.Google Scholar
  8. 8.
    Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull WHO. 2004;82:844–85.PubMedCentralPubMedGoogle Scholar
  9. 9.
    National Eye Institute. Facts about Age-related macular degeneration [NEI Health Information]. http://www.nei.nih.gov/health/maculardegen/armd_facts.asp.
  10. 10.
    Macular Degeneration Foundation 2007. Is anything more precious than your sight? Macular Degeneration Foundation. http://www.mdfoundation.com.au.
  11. 11.
    de Jong PT. Age-related macular degeneration. N Engl J Med. 2006;355:4474–785.Google Scholar
  12. 12.
    Wikipedia Macular degeneration. http://en.wikipedia.org/wiki/Macular_degeneration.
  13. 13.
    Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58:353–63.PubMedGoogle Scholar
  14. 14.
    Zarbin MA. Age-related macular degeneration: review of pathogenesis. Eur J Ophthalmol. 1998;8(4):199–206 (abstract).PubMedGoogle Scholar
  15. 15.
    Nita M, Strzalka-Mrozik B, Grzybowski A, Mazurek U, Romaniuk W. Age-related macular degeneration and changes in the extracellular matrix. Med Sci Monit. 2014;20:1003–16 (abstract).PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Abdelsalam A, Del Priore L, Zarbin MA. Drusen in age-related macular degeneration: pathogenesis, natural course and laser photocoagulation-induced regression. Surv Ophthalmol. 1999;44(1):1–29 (abstract).CrossRefPubMedGoogle Scholar
  17. 17.
    Arnold JJ, Sarks SH. Age related macular degeneration. BMJ. 2000;321:7263–741.CrossRefGoogle Scholar
  18. 18.
    Pauleikhoff D. Drusen in Bruch’s membrane. Their significance for the pathogenesis and therapy of age-associated macular degeneration. Ophthalmologe. 1992;89(5):363–86 (abstract).PubMedGoogle Scholar
  19. 19.
    Lutty G, Grunwalde J, Majji AB, Uyama M, Yoneya S. Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. Mol Vis. 1999;5:35 (abstract).PubMedGoogle Scholar
  20. 20.
    Spraul CW, Lang GE, Grossniklaus HE, Lang GK. Histologic and morphometric analysis of the choroid, Bruch’s membrane and retinal pigment epithelium in postmortem eyes with age –related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol. 1999;44 Suppl 1:S10–32 (abstract).CrossRefPubMedGoogle Scholar
  21. 21.
    Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R, et al. International Age-Related Maculopathy. Epidemiological Study Group. An International classification and Age-Related Maculopathy and Age-Related Macular Degeneration. Surg Ophthalmol. 1995;39:367–74.CrossRefGoogle Scholar
  22. 22.
    Macular Photocoagulation Study Group. Subfoveal neovascular lesion image-related ADM. Guidelines for evaluation and treatment in macular photocoagulation study. Arch Ophthalmol. 1991;109:1242–51.CrossRefGoogle Scholar
  23. 23.
    Bhutto IA, McLead DS, Hasegawa T, Kim SY, Merges C, Tong P, et al. Pigment epithelium – derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid eyes with age related macular degeneration. Exp Eye Res. 2006;82(1):99–110.CrossRefPubMedGoogle Scholar
  24. 24.
    Troutbeck R, Al-Qureshi S, Guymer RH. Therapeutic targeting of the complement system in age-related macular degeneration: a review. Clin Experiment Ophthalmol. 2012;40(1):18–26.CrossRefPubMedGoogle Scholar
  25. 25.
    Broadhead GK, Chang A, McCluster P. Genetics in age-related macular degeneration: current research and implications for future treatment? Asia Pac J Ophthamol. 2012;5:312–8.CrossRefGoogle Scholar
  26. 26.
    Wensor MD, McCarty CA, Stanislavsky YL, Livingston PM, Taylor HR. The prevalence of glaucoma in the Melborne Visual Impairment Project. Ophthalmology 1998;105(4):733–9.Google Scholar
  27. 27.
    Kumarasamy NA, Lam FS, Wong AL, Theoharides TC. Glaucoma: current and developmental concepts for inflammation, pathways and treatment. Eur J Inflammation. 2006;41(3):129–37.Google Scholar
  28. 28.
    Agarwal R, Gupta SK, Agarwal P, Saxena R, Agrawal SS, et al. Current concepts in the pathogenesis of glaucoma. Ind J Ophthalmol. 2001;57(4):257–66.Google Scholar
  29. 29.
    Dimitriou D, Broadway DC. Pathophysiology of glaucoma. In Glaucoma: basic and Clinical perspectives. 2013. p. 32–57. http://www.futuremedicine.com/doi/abs/10,2217/ebo.12420.
  30. 30.
    Kanshik S, Pandau SS, Ram J. Neuroprotection in glaucoma. J Postgrad Med. 2003;49:90–5.CrossRefGoogle Scholar
  31. 31.
    Australian Institute and Health Welfare (AIHW). http://www.aihw.gov.au/workArea/Download.Assit.aspx?id+6442453390. Accessed 10 Jan 2015.
  32. 32.
    Chitkara DK, Hall AB, Rosenthal AR. Pathology and epidemiology of cataract. Section 2-Cataract. Ophthamology; 2010:269–72. Chap 35.Google Scholar
  33. 33.
    Wegener A. Pathophysiology of cataract. 98th annual meeting DOG 2000. http://www.dog.org/2000/e_abstract_2000/214html.
  34. 34.
    Schmitt C, Hockwin O. The mechanisms of cataract formation. J Inher Metab Dis. 1990;13:501–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Kempen JH, O’Colman BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al. The prevalence of diabetic retinopathy among adults in US. Arch Ophthamol. 2004;122(4):552–63 (abstract).CrossRefGoogle Scholar
  36. 36.
    Access my library. Pathophysiology of diabetic retinopathy. Optician.http://www.accessmylibrary.com/coms2/summary_0286-18736025_ITM. Accessed 29 June 2008.
  37. 37.
    Garner A. Developments in the pathology of diabetic retinopathy: a review. J Roy Soc Med. 1981;74:427–31.PubMedCentralPubMedGoogle Scholar
  38. 38.
    Tarr JM, Kaul K, Chopra M, Kohner EM, Chibber R. Pathophysiology of diabetic retinopathy. Ophthalmology; 2013. doi:http://dx.dorg/10.1155.2013/343560.
  39. 39.
    Mathews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM. Risks of progression of retinopathy and vision loss related to tight blood control in type 2 diabetes mellitus. cUKPDS 69. Arch Ophthalmol. 2004;122(1):1631–40.Google Scholar
  40. 40.
    Wirostko B, Wong TY, Simo R. Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res. 2008;27(6):608–21 (abstract).CrossRefPubMedGoogle Scholar
  41. 41.
    Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, et al. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets. 2005;6(4):511–24 (abstract).CrossRefPubMedGoogle Scholar
  42. 42.
    Giese MJ, Speth RC. The ocular renin-angiotensin system: a therapeutic target for the treatment of ocular disease. Pharmacol Thera. 2014;142(1):11–32.CrossRefGoogle Scholar
  43. 43.
    Simo R, Hernandez C. Advances in the medical treatment of diabetic retinopathy. Diabetes Care. 2009;32(8):1556–62.PubMedCentralCrossRefPubMedGoogle Scholar
  44. 44.
    Takagi H, Watanabe D, Suzuma K, Kurimoto M, Suzuma I, Ohashi H, et al. Novel role of erythropoietin in proliferative diabetic retinopathy. Diabetes Res Clin Pract. 2007;77 Suppl 1:S62–4 (abstract).CrossRefPubMedGoogle Scholar
  45. 45.
    Takagi H. Aging and retinal vascular diseases. Nihon Ganka Gakkai Zasshi. 2007;111(3):207–30 (abstract).PubMedGoogle Scholar
  46. 46.
    Fong DS, Aiello L, Gardner TW, King GI, Blankenship G, Cavallerano JD, et al. Diabetic retinopathy. Diabetes Care. 2003;26:S99–102.CrossRefPubMedGoogle Scholar
  47. 47.
    Sino R, Carrasco E, Garcia-Ramirez M, Hernandez C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabet Rev. 2006;2:71–98.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Nages Nagaratnam
    • 1
  • Kujan Nagaratnam
    • 2
  • Gary Cheuk
    • 3
  1. 1.Sydney Medical School (Westmead)The University of SydneyNorth RocksAustralia
  2. 2.Norwest Specialist Medical GroupBella VistaAustralia
  3. 3.Blacktown-Mt Druitt HospitalBlacktownAustralia

Personalised recommendations